Evaluation of Treatments and Services to People with Duchenne Muscular Dystrophy
Evaluation of Treatments and Services to People with Duchenne Muscular Dystrophy
批准号:
8889818
负责人:
Deborah J. Fox
金额:
$10.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2016-09-29
中文摘要
描述(由申请人提供):项目摘要综合来看,Duchenne肌营养不良症(DMD)和较轻微的等位基因变异Becker肌营养不良症(BMD)是最常见的隐性肌营养不良症。据估计,DMD的出生流行率为每3 500名男婴中有1名(2.9‰),骨密度为18,518名男婴中1名(每10 000名男婴中有0.5名)。DBMD是一种进行性疾病,影响包括肌肉、骨骼、呼吸和心血管在内的多个系统。此外,这种疾病可能会对社交、认知和心理发展产生负面影响。因此,一个全面的、多学科的方法来照顾患有DMD的个人是最好的。为了促进这种护理,已经制定了针对DMD患者的治疗和服务建议,其中包括美国神经病学和儿童神经病学学会关于皮质类固醇治疗的建议,美国胸科学会关于呼吸护理的建议,美国儿科学会关于心脏监测的建议,以及最近由DMD护理专家小组制定并由美国疾病控制和预防中心(CDC)协调的2010年关于整体护理的护理考虑。在过去的十年中,肌营养不良症监测跟踪和研究网络(MD STARnet)对DBMD进行了积极的、基于人群的监测,以确定DBMD的流行病学特征,并在亚利桑那州、科罗拉多州、爱荷华州和纽约西部的四个地点对患有DBMD的儿童进行长期跟踪和跟踪。在目前的项目中,我们建议利用和更新MD STARnet收集的数据,以系统地评估向DMD患者提供的治疗和服务之间的一致性,并将所接受的治疗与2010年DMD护理考虑中记录的建议进行比较。这将确定建议的护理标准与实际接受的护理之间的差距。此外,我们将调查MD STARnet确定的医疗保健提供者,以确定提供治疗和服务所涉及的障碍和挑战。MD STARnet的四个站点覆盖的地理区域反映了美国DMD患者的社会人口特征。尽管国际上正在努力研究推荐护理在DMD中的吸收情况(例如,Treat-NMD,加拿大儿科神经肌肉组),但美国还没有进行类似的努力。我们建议的项目将允许在美国DMD患者的人口样本中对DMD关怀考虑的实施情况进行比较评估。该项目有可能对公众健康产生重大影响,因为它评估了对保健考虑的吸收情况,并确定了可能阻碍向患有营养不良的个人提供建议的保健服务的障碍。研究结果的传播将使致力于DMD的卫生保健提供者了解实际护理和推荐护理之间的潜在差异,并提供潜在的解决方案来减少这些差异。
英文摘要
DESCRIPTION (provided by applicant): Project Summary Taken together, Duchenne muscular dystrophy (DMD) and the milder allelic variant Becker muscular dystrophy (BMD) are the most common recessive form of muscular dystrophy. The birth prevalence of DMD has been estimated at 1 in 3,500 (2.9 per 10,000) male births and BMD at 1 in 18,518 (0.5 per 10,000) male births. DBMD are progressive diseases that affect multiple systems including muscular, skeletal, respiratory, and cardiovascular. In addition, social, cognitive and psychological development can be negatively affected by the disease. As a result, a comprehensive, multidisciplinary approach to the care of individuals with DMD is optimal. In order to promote such care, recommendations for treatments and services for individuals with DMD have been developed and include those by the American Academy of Neurology and Child Neurology Society on corticosteroid treatment, American Thoracic Society on respiratory care, American Academy of Pediatrics on cardiac surveillance recommendations and, more recently, the 2010 Care Considerations on whole care developed by panels of experts in the care of DMD and coordinated by the US Centers for Disease Control and Prevention (CDC). Over the past decade, the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) has conducted active, population-based surveillance of DBMD to characterize the epidemiology and develop long-term follow-up and tracking of children with DBMD across four sites in Arizona, Colorado, Iowa, and western New York. For the current project, we propose to utilize and update data collected by the MD STARnet to systematically evaluate agreement between treatments and services provided to individuals who have DMD and compare treatment received to the recommendations documented in the 2010 DMD Care Considerations. This will identify gaps between recommended standards of care and actual care received. Additionally, we will survey health care providers identified by the MD STARnet to identify barriers and challenges involved in the delivery of treatments and services. The geographical area covered by the four sites of the MD STARnet mirrors the socio-demographic characteristics of people with DMD in the United States. Although international efforts to examine the uptake of recommended care in DMD are underway (e.g., TREAT-NMD, Canadian Pediatric Neuromuscular group), similar efforts have not been undertaken in the United States. Our proposed project will allow a comparative evaluation of the implementation of the DMD Care Considerations in a population-based sample of individuals with DMD within the US. This project has the potential of having a major public health impact by evaluating the uptake of care considerations and identifying barriers that may prevent the delivery of recommended health care to individuals with DMD. The dissemination of the findings will inform health care providers dedicated to DMD of the potential disparities between actual and recommended care and provide potential solutions for reducing these discrepancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comp A-NY State Surveillance and Research of MD and Neuromuscular Disorders
-
批准号:8815408
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2014
-
负责人:Deborah J. Fox
-
依托单位:
Comp C-NY State Surveillance and Research of MD and Neuromuscular Disorders:Enhanced Activities/Abstractor Training and QA/QC
-
批准号:8813231
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2014
-
负责人:Deborah J. Fox
-
依托单位:
Evaluation of Treatments and Services to People with Duchenne Muscular Dystrophy
-
批准号:8621354
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2013
-
负责人:Deborah J. Fox
-
依托单位:
Evaluation of Treatments and Services to People with Duchenne Muscular Dystrophy
-
批准号:8727277
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2013
-
负责人:Deborah J. Fox
-
依托单位:
NEW YORK FETAL ALCOHOL SYNDROMS SURVEILLANCE IN WESTERN NEW YORK
-
批准号:8484215
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2009
-
负责人:Deborah J. Fox
-
依托单位:
海外基金